Swiss Life Asset Management’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-47,130
Closed -$4.68M 540
2019
Q3
$4.68M Buy
47,130
+36,363
+338% +$3.46M 0.06% 185
2019
Q2
$995K Buy
10,767
+951
+10% +$90.3K 0.01% 391
2019
Q1
$926K Buy
+9,816
New +$858K 0.01% 371
2018
Q4
Sell
-21,496
Closed -$1.92M 530
2018
Q3
$1.92M Buy
21,496
+8,818
+70% +$779K 0.03% 327
2018
Q2
$1.01M Sell
12,678
-68,063
-84% -$5.65M 0.02% 383
2018
Q1
$7.2M Sell
80,741
-135,015
-63% -$13M 0.13% 155
2017
Q4
$22.5M Buy
215,756
+77,135
+56% +$8.7M 0.5% 67
2017
Q3
$20.2M Buy
138,621
+4,280
+3% +$583K 0.54% 58
2017
Q2
$17.4M Hold
134,341
0.45% 65
2017
Q1
$16.7M Buy
134,341
+6,531
+5% +$782K 0.45% 66
2016
Q4
$14.8M Buy
127,810
+41,330
+48% +$4.6M 0.5% 67
2016
Q3
$9.04M Buy
86,480
+5,714
+7% +$618K 0.31% 71
2016
Q2
$7.97M Hold
80,766
0.33% 76
2016
Q1
$8.08M Hold
80,766
0.34% 76
2015
Q4
$9.67M Hold
80,766
0.43% 67
2015
Q3
$8.74M Buy
80,766
+735
+0.9% +$91.2K 0.43% 67
2015
Q2
$9.26M Sell
80,031
-340
-0.4% -$38.9K 0.32% 60
2015
Q1
$9.27M Buy
+80,371
New +$9.6M 0.37% 61

Other funds holding CELG

Swiss Life Asset Management's CELG Position: Q4 2019 in Review

Swiss Life Asset Management sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 47,130 shares — an estimated $4.68M sold.

Swiss Life Asset Management first reported a position in CELG in Q1 2015 and held it in 18 quarters. The position peaked at $22.5M in Q4 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Swiss Life Asset Management reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Swiss Life Asset Management sold 47,130 Celgene Corp shares in Q4 2019, an estimated $4.68M.
  • Swiss Life Asset Management first reported a position in Celgene Corp in Q1 2015 and held it in 18 quarters.
  • Swiss Life Asset Management's Celgene Corp position peaked at $22.5M in Q4 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Swiss Life Asset Management's 13F filing for Q4 2019, filed 29 Dec 2025.